Sophia Rakrouki
YOU?
Author Swipe
View article: O-032 Fertility preservation in adolescent and young adult transgender men
O-032 Fertility preservation in adolescent and young adult transgender men Open
Study question Is hormone therapy impacting fertility preservation (FP) and desire of parenthood in transgender adolescents and young adult men? Summary answer Androgen therapy (AT) does not impact FP yield. Most of them had a desire of pa…
View article: P-379 Fertility outcomes several years after fertility preservation for endometriosis
P-379 Fertility outcomes several years after fertility preservation for endometriosis Open
Study question To study the fertility outcomes of women who tried to conceive at least 2 years after fertility preservation (FP) for endometriosis. Summary answer To advise patients with endometriosis on the benefit of FP, particulary on t…
View article: Effect of breast cancer prognostic factors on ovarian reserve and response in fertility preservation
Effect of breast cancer prognostic factors on ovarian reserve and response in fertility preservation Open
Breast cancer prognostic factors do not influence ovarian reserve markers or response to ovarian stimulation in fertility preservation. Therefore, tumour grade, triple-negative status, HER2 overexpression and high Ki67 should not alter the…
View article: Fertility outcomes several years after urgent fertility preservation for patients with breast cancer
Fertility outcomes several years after urgent fertility preservation for patients with breast cancer Open
Although pregnancy rates after fertility preservation for patients with BC are low, most conceptions are achieved without medical assistance. Our findings provide useful information to advise women on the different techniques of fertility …
View article: P-411 Cumulative live-birth rate after oocyte vitrification for fertility preservation (FP) in oncologic or benign conditions: a retrospective comparative monocentric study
P-411 Cumulative live-birth rate after oocyte vitrification for fertility preservation (FP) in oncologic or benign conditions: a retrospective comparative monocentric study Open
Study question Does cumulative livebirth-rate (CLBR) after reutilization of vitrified oocytes differ between patients having undergone fertility preservation (FP) for oncologic (onco-FP) reason or benign conditions (benign-FP)? Summary ans…
View article: O-274 Influence of breast cancer prognostic factors on ovarian reserve and response to ovarian stimulation in fertility preservation
O-274 Influence of breast cancer prognostic factors on ovarian reserve and response to ovarian stimulation in fertility preservation Open
Study question Do breast cancer (BC) prognostic factors influence ovarian reserve and response to controlled ovarian hyperstimulation (COH) in the context of fertility preservation (FP)? Summary answer BC prognostic factors do not influenc…
View article: O-084 Fertility outcomes several years after urgent fertility preservation (FP) for breast cancer
O-084 Fertility outcomes several years after urgent fertility preservation (FP) for breast cancer Open
Study question What are the fertility outcomes of women who tried to conceive after breast cancer treatment and FP? Summary answer Three to-ten years after FP for breast cancer, less than half of patients tried to conceive but 39% of them …
View article: Response to Ovarian Stimulation for Urgent Fertility Preservation before Gonadotoxic Treatment in BRCA-Pathogenic-Variant-Positive Breast Cancer Patients
Response to Ovarian Stimulation for Urgent Fertility Preservation before Gonadotoxic Treatment in BRCA-Pathogenic-Variant-Positive Breast Cancer Patients Open
BRCA 1/2 pathogenic variants increase the risk of developing early and aggressive breast cancers (BC). For these patients, fertility potential can be directly affected by oncologic treatments. In addition, evidence indicates that BRCA-muta…